Cargando…

Inhibition of lysis of sensitised tumour cells in the presence of complement.

Detalles Bibliográficos
Autor principal:	Hartveit, F.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1965
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071336/ https://www.ncbi.nlm.nih.gov/pubmed/5833077

Ejemplares similares

Secondary immunological lysis in Ehrlich's ascites carcinoma.
por: Hartveit, F.
Publicado: (1965)

The Complement Content of the Serum of Normal as Opposed to Tumour Bearing Mice
por: Hartveit, F.
Publicado: (1964)

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy
por: Shapiro, Daniel D., et al.
Publicado: (2023)

LYSIS OF ERYTHROCYTES BY COMPLEMENT IN THE ABSENCE OF ANTIBODY
por: Götze, Otto, et al.
Publicado: (1970)

Immunology: Are complement lysis and lymphocytotoxicity analogous?
por: Lachmann, P.J.
Publicado: (1983)

Tumour lysis syndrome
por: Grewal, Keerat, et al.
Publicado: (2023)

Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.
por: BjÃ¸rge, L., et al.
Publicado: (1997)

Cinnarizine and flunarizine as radiation sensitisers in two murine tumours.
por: Wood, P. J., et al.
Publicado: (1988)

Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis
por: Bushey, Ryan T., et al.
Publicado: (2021)

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation
por: Hanna, Conor, et al.
Publicado: (2020)

Antibody mediated complement dependent lysis of virus infected cells
por: Oldstone, Michael B. A., et al.
Publicado: (1979)

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis
por: Marini, Patrizia, et al.
Publicado: (2005)

Complement-mediated adipocyte lysis by nephritic factor sera
Publicado: (1993)

REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLS : I. THE CHARACTERIZATION OF THE INDICATOR FACTOR AND ITS IDENTIFICATION AS C7
por: Thompson, R. A., et al.
Publicado: (1970)

IMMUNE LYSIS OF NORMAL HUMAN AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELLS : III. THE MEMBRANE DEFECTS CAUSED BY COMPLEMENT LYSIS
por: Rosse, Wendell F., et al.
Publicado: (1966)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
por: Shaik Fakiruddin, Kamal, et al.
Publicado: (2018)

Tumour extracellular vesicle‐derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement‐dependent cytotoxicity of tumour cells
por: Mao, Xiaowen, et al.
Publicado: (2020)

Tumour cells are sensitised to ferroptosis via RB1CC1‐mediated transcriptional reprogramming
por: Xue, Xiangfei, et al.
Publicado: (2022)

Radiation-Sensitising Effects of Antennapedia Proteins (ANTP)-SmacN7 on Tumour Cells
por: Du, Li Qing, et al.
Publicado: (2013)

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress
por: Herbert, Katharine J., et al.
Publicado: (2020)

Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition
por: Arnould, Stéphanie, et al.
Publicado: (2017)

Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
por: Holt, Amy K., et al.
Publicado: (2023)

The Rôle of the Large Peritoneal Macrophage in Tumour Homograft Rejection
por: Hartveit, F.
Publicado: (1964)

Does progesterone receptor in human breast cancer reflect the mast-cell content of the tumour tissue?
por: Thoresen, S., et al.
Publicado: (1982)

REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLS : II. THE CHARACTERIZATION OF ACTIVATED REACTOR AS C56 AND THE PARTICIPATION OF C8 AND C9
por: Lachmann, P. J., et al.
Publicado: (1970)

Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction
por: Lickliter, J D, et al.
Publicado: (2007)

Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody
Publicado: (1979)

Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers
por: Mallik, Prabhat K., et al.
Publicado: (2021)

Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
por: Spencer, David A., et al.
Publicado: (2022)

The Effect of Tumour Dosage on the Blood Content of Ehrlich's Ascites Carcinoma
por: Hartveit, F.
Publicado: (1963)

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
por: de Bruijn, M T, et al.
Publicado: (2010)

Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis
por: Miller, Hannah W., et al.
Publicado: (2022)

Tumour lysis as a factor affecting blood levels of CEA.
por: Quayle, J. B.
Publicado: (1982)

A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells
por: Cruz, Jonathan W., et al.
Publicado: (2019)

A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement
por: Xu, Yuanyong, et al.
Publicado: (2009)

Spontaneous Tumour Lysis Syndrome in a Multiple Myeloma
por: Huzmeli, Can, et al.
Publicado: (2016)

Axitinib/pembrolizumab: Tumour-lysis-syndrome: case report
Publicado: (2020)

Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation
por: Chen, Jin Y., et al.
Publicado: (2020)

Steroid-induced tumour lysis syndrome in small-cell lung cancer
por: Khan, Fasihul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9u6hmf4qs5ct0n5jptfbv0dv4m